Search research articles
Contact Us
Filters
Showing results (381-390 of 413) with videos related to
Page
of 42
Sort By:
Cell Death & Disease
|
May 11, 2023
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER<sup>-</sup> breast tumors that lead to poor outcome
Robert Y S Cheng, Lisa A Ridnour, Adelaide L Wink, et al.
Redox Biology
|
November 14, 2022
Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density
Veena Somasundaram, Lisa A Ridnour, Robert Ys Cheng, et al.
JCI Insight
|
July 15, 2025
Elevated tumor NOS2/COX2 promotes immunosuppressive phenotypes associated with poor survival in ER- breast cancer
Lisa A Ridnour, Robert Ys Cheng, William F Heinz, et al.
Cancers
|
August 7, 2021
Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition
Jeffrey R Whiteaker, Tao Wang, Lei Zhao, et al.
The American Journal of Pathology
|
March 24, 2023
Histopathology and SARS-CoV-2 Cellular Localization in Eye Tissues of COVID-19 Autopsies
H Nida Sen, Kevin M Vannella, Yujuan Wang, et al.
Biorxiv : the Preprint Server for Biology
|
January 8, 2024
Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patients
Lisa A Ridnour, Robert Y S Cheng, William F Heinz, et al.
Cancer Research Communications
|
October 2, 2024
Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast Cancer
Lisa A Ridnour, William F Heinz, Robert Y S Cheng, et al.
Frontiers in Oncology
|
May 19, 2023
A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials
Jeffrey R Whiteaker, Lei Zhao, Regine M Schoenherr, et al.
JCI Insight
|
June 24, 2024
Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors
Lisa A Ridnour, Robert Ys Cheng, Noemi Kedei, et al.
Pathogens (Basel, Switzerland)
|
July 29, 2023
Pulmonary Co-Infections Detected Premortem Underestimate Postmortem Findings in a COVID-19 Autopsy Case Series
Andrew P Platt, Benjamin T Bradley, Nadia Nasir, et al.
Page
of 42
Search research articles
Search
Showing results (381-390 of 413) with videos related to
Sort By:
Page
of 42
Cell Death & Disease
|
May 11, 2023
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER<sup>-</sup> breast tumors that lead to poor outcome
Robert Y S Cheng, Lisa A Ridnour, Adelaide L Wink, et al.
Redox Biology
|
November 14, 2022
Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density
Veena Somasundaram, Lisa A Ridnour, Robert Ys Cheng, et al.
JCI Insight
|
July 15, 2025
Elevated tumor NOS2/COX2 promotes immunosuppressive phenotypes associated with poor survival in ER- breast cancer
Lisa A Ridnour, Robert Ys Cheng, William F Heinz, et al.
Cancers
|
August 7, 2021
Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition
Jeffrey R Whiteaker, Tao Wang, Lei Zhao, et al.
The American Journal of Pathology
|
March 24, 2023
Histopathology and SARS-CoV-2 Cellular Localization in Eye Tissues of COVID-19 Autopsies
H Nida Sen, Kevin M Vannella, Yujuan Wang, et al.
Biorxiv : the Preprint Server for Biology
|
January 8, 2024
Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patients
Lisa A Ridnour, Robert Y S Cheng, William F Heinz, et al.
Cancer Research Communications
|
October 2, 2024
Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast Cancer
Lisa A Ridnour, William F Heinz, Robert Y S Cheng, et al.
Frontiers in Oncology
|
May 19, 2023
A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials
Jeffrey R Whiteaker, Lei Zhao, Regine M Schoenherr, et al.
JCI Insight
|
June 24, 2024
Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors
Lisa A Ridnour, Robert Ys Cheng, Noemi Kedei, et al.
Pathogens (Basel, Switzerland)
|
July 29, 2023
Pulmonary Co-Infections Detected Premortem Underestimate Postmortem Findings in a COVID-19 Autopsy Case Series
Andrew P Platt, Benjamin T Bradley, Nadia Nasir, et al.
Page
of 42